Thesis Open Access
BY: Dr. Worku Wegayehu (MD)
<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
<rdf:Description rdf:about="https://doi.org/10.20372/nadre:25793">
<rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
<dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
<dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.20372/nadre:25793</dct:identifier>
<foaf:page rdf:resource="https://doi.org/10.20372/nadre:25793"/>
<dct:creator>
<rdf:Description>
<rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
<foaf:name>BY: Dr. Worku Wegayehu (MD)</foaf:name>
</rdf:Description>
</dct:creator>
<dct:title>PREDICTORS OF TIME TO BIOCHEMICAL EUTHYROIDISM IN TOXIC GOITER PATIENTS TREATED WITH ANTI-THYROID DRUGS: A FIVE-YEAR RETROSPECTIVE COHORT STUDY</dct:title>
<dct:publisher>
<foaf:Agent>
<foaf:name>Zenodo</foaf:name>
</foaf:Agent>
</dct:publisher>
<dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2026</dct:issued>
<dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2026-08-24</dct:issued>
<owl:sameAs rdf:resource="https://nadre.ethernet.edu.et/record/25793"/>
<adms:identifier>
<adms:Identifier>
<skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://nadre.ethernet.edu.et/record/25793</skos:notation>
<adms:schemeAgency>url</adms:schemeAgency>
</adms:Identifier>
</adms:identifier>
<dct:isVersionOf rdf:resource="https://doi.org/10.20372/nadre:25792"/>
<dct:isPartOf rdf:resource="https://nadre.ethernet.edu.et/communities/20-25"/>
<dct:description><p><strong>ABSTRACT</strong></p> <p><strong>Introduction:</strong> Toxic goiter is a common endocrine disorder requiring long-term anti-thyroid drug therapy, yet evidence on time to biochemical euthyroidism and its predictors is limited in resource-limited settings. This study aimed to determine time to biochemical euthyroidism and its predictors among patients with toxic goiter treated with anti-thyroid drugs at Wallaga University Comprehensive Specialized Hospital.</p> <p><strong>Methods</strong>: A five-year retrospective cohort study was conducted using 120 patient records selected from 143 eligible cases between January 1, 2021 and December 31, 2025. Data were collected using a structured checklist via Epi-data version 3.1 and analyzed using SPSS version 27. The Kaplan&ndash;Meier survival curve with log-rank test was used to compare differences in time to biochemical euthyroidism across categorical variables. Variables with a p-value &lt;0.25 in bivariable analysis were entered into the multivariable Cox proportional hazards regression model. The proportional hazards assumption was assessed using Schoenfeld residuals and log-minus-log survival plots, and no significant violation was observed. Model fitness was evaluated using the Cox&ndash;Snell residual goodness-of-fit test, which indicated that the final model adequately fitted the data. Statistical significance was declared at p &lt; 0.05.</p> <p><strong>Results</strong>: The response rate was 83.9%. The mean age of participants was 38.6 &plusmn; 12.4 years. The median time to biochemical euthyroidism was 6 months, based on Kaplan&ndash;Meier survival analysis. Rural residence (AHR = 0.68, 95% CI: 0.50, 0.92) and higher baseline FT4 levels (AHR = 0.94, 95% CI: 0.90, 0.98) were significantly associated with delayed time to euthyroidism.</p> <p><strong>Conclusion and recommendation</strong>: Although a substantial proportion achieved euthyroidism early, variability in response resulted in a broader distribution of time to normalization. Rural residence and higher baseline FT4 levels were significant predictors of delayed response. Strengthening early diagnosis, improving follow-up systems, and enhancing rural healthcare access are essential to improve treatment outcomes.</p> <p>&nbsp;</p> <p>&nbsp;</p> <p><strong>Keywords:</strong> Toxic goiter, biochemical euthyroidism, survival analysis, Ethiopia</p> <p>&nbsp;</p> <p>&nbsp;</p> <p>&nbsp;</p></dct:description>
<dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
<dct:accessRights>
<dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
<rdfs:label>Open Access</rdfs:label>
</dct:RightsStatement>
</dct:accessRights>
<dcat:distribution>
<dcat:Distribution>
<dcat:accessURL rdf:resource="https://doi.org/10.20372/nadre:25793"/>
</dcat:Distribution>
</dcat:distribution>
<dcat:distribution>
<dcat:Distribution>
<dcat:accessURL rdf:resource="https://doi.org/10.20372/nadre:25793"/>
<dcat:byteSize>2226176</dcat:byteSize>
<dcat:downloadURL rdf:resource="https://nadre.ethernet.edu.et/record/25793/files/Dr. Worku Wegayehu Final Thesis_May 11, 2026.doc"/>
<dcat:mediaType>application/msword</dcat:mediaType>
</dcat:Distribution>
</dcat:distribution>
</rdf:Description>
</rdf:RDF>
| All versions | This version | |
|---|---|---|
| Views | 0 | 0 |
| Downloads | 0 | 0 |
| Data volume | 0 Bytes | 0 Bytes |
| Unique views | 0 | 0 |
| Unique downloads | 0 | 0 |